Yasuo Tsutsumi

发表

[Recent topics on development of nanomaterials and nano-safety science].

Yasuo Yoshioka, Yasuo Tsutsumi, 2014, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

A novel method for construction of gene fragment library to searching epitopes.

Yasuo Tsutsumi, Maki Kawamura, Hiroko Shibata, 2006, Biochemical and biophysical research communications.

[Recent topics about nano-safety science and its future].

Yasuo Yoshioka, Yasuo Tsutsumi, Tomoaki Yoshikawa, 2013, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[Nano-safety science for sustainable nanotechnology].

Yasuo Yoshioka, Yasuo Tsutsumi, 2014, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[Safety assessment of nanomaterials using toxicokinetics and toxicoproteome analysis].

Yasuo Tsutsumi, Tomoaki Yoshikawa, Hiromi Nabeshi, 2010, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

Development of a Novel DDS Technology for Optimization of Protein Therapies

Yasuo Tsutsumi, 2004 .

[Application of nanomaterials for drug innovation and their risks].

Yasuo Tsutsumi, Shin-Ichi Tsunoda, 2008, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

Silica nanoparticles as hepatotoxicants.

Yasuo Tsutsumi, Masuo Kondoh, Kiyohito Yagi, 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Optimal site-specific PEGylation of mutant TNF-α improves its antitumor potency

Yasuo Yoshioka, Yasuo Tsutsumi, Hiroko Shibata, 2004 .

Allergic Responses Induced by the Immunomodulatory Effects of Nanomaterials upon Skin Exposure

Toshiro Hirai, Yasuo Yoshioka, Yasuo Tsutsumi, 2017, Front. Immunol..

Carbon Nanotubes Elicit DNA Damage and Inflammatory Response Relative to Their Size and Shape

Yasuo Yoshioka, Yasuo Tsutsumi, Haruhiko Kamada, 2010, Inflammation.

Creation and X-ray Structure Analysis of the Tumor Necrosis Factor Receptor-1-selective Mutant of a Tumor Necrosis Factor-α Antagonist*

Akira Yamamoto, Yasuo Yoshioka, Takao Hayakawa, 2008, Journal of Biological Chemistry.

Intracellular trafficking of particles inside endosomal vesicles is regulated by particle size

Takeharu Nagai, Yasuo Yoshioka, Yoshiyuki Arai, 2017, Journal of controlled release : official journal of the Controlled Release Society.

Potential Hazards of Skin Exposure to Nanoparticles

Toshiro Hirai, Yasuo Yoshioka, Yasuo Tsutsumi, 2016 .

Protein corona changes mediated by surface modification of amorphous silica nanoparticles suppress acute toxicity and activation of intrinsic coagulation cascade in mice

Toshiro Hirai, Yasuo Yoshioka, Yasuo Tsutsumi, 2015, Nanotechnology.

Fusogenic liposome delivers encapsulated nanoparticles for cytosolic controlled gene release.

Mitsuru Akashi, Yasuo Tsutsumi, Tadanori Mayumi, 2005, Journal of controlled release : official journal of the Controlled Release Society.

Amorphous nanosilica induce endocytosis-dependent ROS generation and DNA damage in human keratinocytes

Toshiro Hirai, Yasuo Yoshioka, Yasuo Tsutsumi, 2011, Particle and Fibre Toxicology.

Silica and titanium dioxide nanoparticles cause pregnancy complications in mice.

Yasuo Yoshioka, Yasuo Tsutsumi, Haruhiko Kamada, 2011, Nature nanotechnology.

Site-specific PEGylation of a lysine-deficient TNF-α with full bioactivity

Yasuo Yoshioka, Yasuo Tsutsumi, Yohei Mukai, 2003, Nature Biotechnology.

Amorphous nanosilicas induce consumptive coagulopathy after systemic exposure

Toshiro Hirai, Yasuo Yoshioka, Yasuo Tsutsumi, 2012, Nanotechnology.

A strategy for efficient cross-presentation of CTL-epitope peptides leading to enhanced induction of in vivo tumor immunity.

Yasuo Yoshioka, Yasuo Tsutsumi, Yohei Mukai, 2007, Journal of controlled release : official journal of the Controlled Release Society.

Solution of the Structure of the TNF-TNFR2 Complex

Yasuo Yoshioka, Yasuo Tsutsumi, Yohei Mukai, 2010, Science Signaling.

Neutralizing antibody evasion ability of adenovirus vector induced by the bioconjugation of methoxypolyethylene glycol succinimidyl propionate (MPEG-SPA).

Takao Hayakawa, Yasuo Tsutsumi, Tadanori Mayumi, 2004, Biological & pharmaceutical bulletin.

Fast binding kinetics and conserved 3D structure underlie the antagonistic activity of mutant TNF: useful information for designing artificial proteo-antagonists.

Yasuo Yoshioka, Yasuo Tsutsumi, Hiroko Shibata, 2009, Journal of biochemistry.